肝动脉灌注和灌注栓塞治疗中晚期肝癌  

Treatment of Middle or Advanced Stage Hepatocellular Carcinoma with Hepatic Arterial Infusion and Embolization

作　　者：李保全[1] 朱春生[1] 赵宏伟[1] 

机构地区：[1]解放军第159医院放射科,河南驻马店463000

出　　处：《临床军医杂志》2003年第1期51-53,共3页Clinical Journal of Medical Officers

摘　　要：目的　总结肝动脉灌注和灌注栓塞治疗中晚期肝癌的疗效。方法　采用seldinger技术 ,经皮股动脉穿刺插管 ,对16 8例中晚期肝癌行肝动脉灌注化疗 (TAI)和灌注栓塞 (TAE)。结果　生存率TAI组患者生存 0 .5年占 5 6 .5 %,1年者占2 1.7%,2年者占 2 .2 %;TAE组生存 0 .5年者占 90 .8%,1年者占 6 1.8%,2年者占 31.6 %。结论　肝动脉灌注、栓塞治疗中晚期肝癌是一种姑息性疗法 ,TAE效果优于TAI。Objective To sum up the effects of transcatheter arterial infusion chemotherapy (TAI) and transcatheter arterial embolization (TAE) on middle or advanced stage hepatocellular carcinoma.Methods TAI and TAE were performed in 168 patients with middle or advanced stage hepatocellular carcinoma via femoral artery catheterization through Seldinger's technique.Results The mean survival rates of 0.5, 1 year and 2 years were 56.5% , 21.7% and 2.2% in TAI group, while they were 90.8% ,61.8% and 31.6% in TAE group,respectively.Conclusion As a palliative therapy,the effect of TAE is better than that of TAI.

关 键 词：肝动脉灌注栓塞 介入治疗 药物方法 肝肿瘤 

分 类 号：R735.7[医药卫生—肿瘤]